Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by jdstoxon Jul 06, 2018 1:44pm
171 Views
Post# 28278736

RE:RE:RE:do you think

RE:RE:RE:do you thinkI don't like the share price one damn bit, regardless. But I can't comment on what people should do with their money and shares.

But I'm not going to take my eye off the ball even if the market may. Neither is the company. Bioasis and its SAB know how things are going. Does xB3 continue to have the potential it's always had?

I suspect that the market knows the potential. A couple of sellers willing to sell this down can't change what xB3 is. xB3 is not a share price or a NASDAQ listing. It's a technology that can be worth a lot if it continues to show in these much-needed studies that it's everything we always hoped it would be.

Who knows what the sellers' real motives are? I think that people should turn that rock over in their minds and think about it. There are more possibilities than that Bioasis isn't worth the investment or worth waiting for. 

jdstox

Bullboard Posts